Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Posner

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
British Journal of Clinical Pharmacology|January 1, 1994
Examination of some factors responsible for a food-induced increase in absorption of atovaquoneP E Rolan, A J Mercer, B C Weatherley, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairmentJ P Fillastre, M Godin, B Legallicier, et al.
British Journal of Clinical Pharmacology|July 1, 1986
Comparative disposition of codeine and pholcodine in man after single oral dosesJ W Findlay, A S Fowle, R F Butz, et al.
British Journal of Clinical Pharmacology|April 1, 1993
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjectsP E Rolan, J E Parker, S J Gray, et al.
Translational Psychiatry|November 2, 2016
Alterations in amygdala-prefrontal circuits in infants exposed to prenatal maternal depressionJ Posner, J Cha, A K Roy, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 27, 1999
Extracorporeal membrane oxygenation for patients with refractory ventricular arrhythmiasM I Cohen, J W Gaynor, V Ramesh, et al.
Journal of Environmental Quality|July 1, 2004
Impact of preferential flow at varying irrigation rates by quantifying mass fluxesT J Gish, K J S Kung, D C Perry, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and womenR W Peck, E J Seaber, R M Dixon, et al.
Current Oncology (Toronto, Ont.)|December 3, 2015
Physician preferences for bone metastasis drug therapy in CanadaJ Arellano, J M González, Y Qian, et al.
British Journal of Clinical Pharmacology|June 1, 1997
The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90)E Seaber, N On, R M Dixon, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
British Journal of Clinical Pharmacology|January 1, 1994
Examination of some factors responsible for a food-induced increase in absorption of atovaquoneP E Rolan, A J Mercer, B C Weatherley, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairmentJ P Fillastre, M Godin, B Legallicier, et al.
British Journal of Clinical Pharmacology|July 1, 1986
Comparative disposition of codeine and pholcodine in man after single oral dosesJ W Findlay, A S Fowle, R F Butz, et al.
British Journal of Clinical Pharmacology|April 1, 1993
The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjectsP E Rolan, J E Parker, S J Gray, et al.
Translational Psychiatry|November 2, 2016
Alterations in amygdala-prefrontal circuits in infants exposed to prenatal maternal depressionJ Posner, J Cha, A K Roy, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 27, 1999
Extracorporeal membrane oxygenation for patients with refractory ventricular arrhythmiasM I Cohen, J W Gaynor, V Ramesh, et al.
Journal of Environmental Quality|July 1, 2004
Impact of preferential flow at varying irrigation rates by quantifying mass fluxesT J Gish, K J S Kung, D C Perry, et al.
Clinical Pharmacology and Therapeutics|April 29, 1998
The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and womenR W Peck, E J Seaber, R M Dixon, et al.
Current Oncology (Toronto, Ont.)|December 3, 2015
Physician preferences for bone metastasis drug therapy in CanadaJ Arellano, J M González, Y Qian, et al.
British Journal of Clinical Pharmacology|June 1, 1997
The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90)E Seaber, N On, R M Dixon, et al.
Pageof 11